ADMA Biologics, Inc.(NasdaqGM:ADMA) dropped from Russell 3000E Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.73 USD | +2.54% |
|
+14.80% | +203.76% |
07-09 | Cantor Fitzgerald Adjusts Price Target on ADMA Biologics to $15 From $10, Maintains Overweight Rating | MT |
07-01 | ADMA Biologics, Inc.(NasdaqGM:ADMA) dropped from Russell 3000E Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+203.76% | 3.18B | |
+7.46% | 100B | |
+8.42% | 42.34B | |
-13.04% | 32.76B | |
+80.48% | 29.46B | |
-10.92% | 16.31B | |
+1.93% | 14.39B | |
-6.77% | 12.23B | |
+177.16% | 10.47B | |
-1.35% | 8.97B |
- Stock Market
- Equities
- ADMA Stock
- News ADMA Biologics, Inc.
- ADMA Biologics, Inc.(NasdaqGM: ADMA) dropped from Russell 3000E Value Index